If you are using mobile devices, please swipe to the right to view the full content
THURSDAY, 10 OCTOBER 2024
The pre-congress is by invitation only.
TIME | PRE-CONGRESS WORKSHOP | |
08:45-09:00 | Registration & Tea | |
09:00-09:15 | Welcome and introduction | Marniza Bt Saad / Soo Hoo Hwoei Fen |
09:15-09:30 | Lecture 1: Teaching Clinical Reasoning in a Busy Practice | Marniza Bt Saad |
09:30-09:45 | Lecture 2: Assessment, evaluation & appraisal | Fong Chin Heng |
09:45-10:30 | Skill activity 1: WBA: Conducting & appraising CBD (with trainees) | Fong Chin Heng + All facilitator |
10:30-10:45 | Lecture 3: Reflective practice | Marfuah Nik Eezamuddeen |
10:45-11:30 | Skill activity 2: Reflective Practice in ‘Postgraduate training’ (with trainees) | Marfuah Nik Eezamuddeen + All facilitator |
11:30-11:45 | Break | |
11:45-12:00 | Lecture 4: The Effective Supervisor | Rachel Cooper |
12:00-12:15 | Lecture 5: How to Give Productive Feedback that Leads to Positive Changes? | Tom Rogue |
12:15-13:00 | Skill Activity 3: Giving Productive Feedback | Tom Roogue & Rachel Cooper |
12:45-13:30 | Lunch | |
13:30-13:45 | Lecture 6: Managing poor performance | Soo Hoo Hwoei Fen |
13:45 – 14:15 | Skill Activity 4: Managing poor performance-Different case scenarios | Soo Hoo Hwoei Fen + All facilitator |
14.15-15:00 | Skill Activity 5: Awaiting HITAP feedback | Chittawan Poonsiri |
15:00-15:15 | Break | Break |
15:15-15:30 | Lecture 7: Coaching trainee in era with abundance of online resources | Melvin Chua Lee Kiang |
15.30-16.00 | Photo taking, Tea & Closing | All |
FRIDAY, 11 OCTOBER 2024
TIME | BALLROOM 1 | BALLROOM 2 | BALLROOM 3 |
0800-0930 | REGISTRATION |
||
0930-1100 | Grand Forum: Bridging the Gaps Chairperson: Mohamed Ibrahim Bin Dato' Hj. Abdul Wahid & Tan Hui Ling |
||
0930-0950 | The Ideal: The Comprehensive Oncological Care Of The Future - Taking A Wider View On Improving Future Cancer Outcomes - Radiotherapy Access Yeoh Kheng Wei |
||
0950-1005 | The Challenge: Escalating cost of cancer treatment: what do we expect in the future? (radiotherapy access) Dr Sharliza Mohd Salleh |
||
1005-1020 | Singapore: Learning The Experience Of The "Cancer Drug Reimbursement System" In Singapore Ravindran Kanesvaran, Singapore |
||
1020-1030 | Thailand: Cancer Drug Reimbursement in Thailand: Current Landscape and Future Directions Chittawan Poonsiri, Thailand |
||
1030-1040 | Malaysia: Where Do We Stand In Malaysia, In Term Of Drug Affordability And National Cancer Drug Reimbursement System? Mastura Md Yusof |
||
1040-1100 | Forum Discussion | ||
1100-1130 | Opening Ceremony - Opening of ASCOMOS Penang 2024 | ||
1130-1230 | KEYNOTE ADDRESS: ONCOLOGY TRAINING - What Do We Need For The Future? Chairperson: Lee Cheen Leng Speaker: Rachel Cooper, United Kingdom Marniza Bt Saad Soo Hoo Hwoei Fen |
||
1230-1300 | Repartitioning of halls | ||
1300-1400 |
|
LUNCH SYMPOSIUM 2 | LUNCH SYMPOSIUM 3 |
1400-1530 | Early Lung Cancer Chairpersons: |
Early Breast Cancer Chairpersons: Doris Chow Sze Ying |
Hepatobiliary Chairpersons: Rosmawati Binti Mohamed |
1400-1420 | Lung Cancer Screening & Smoking Cessation Liam Chong Kin |
Anthracyclines - Is It Still Relevant In Early Breast Cancer? Samuel Ow, Singapore |
Combination Therapy In Intermediate HCC: Where We Stand? Stephen Chan, Hong Kong |
1420-1440 | Debate: Neoadjuvant Chemo-Immunotherapy Before Surgery Should Be The SOC ForSstage IB (>4cm) - IIIA NSCLC Proponent: Cheah Soon Keat Opponent: TBC |
Adjuvant Endocrine Therapy In Premenopausal Women - Beyond Tamoxifen Kiley Loh |
Indications Of SBRT In Hepatobiliary Cancer, Clinical Aspects Of Radiotherapy Planning Maria Hawkins, United Kingdom |
1440-1500 | How Do I Treat Stage III NCLSL Prof Michael Chao, Australia |
Role Of Rt/Axillary Treatment In The Era Of Neoadjuvant Therapy Mastura Md Yusof |
MDT Case Discussion Lim Yueh Ni Loh Kok Beng Jasjit Singh Nijhar |
1500-1530 | (10 minutes Q&A) | Q&A | Q&A |
1530-1610 |
From Progression to Possibilities: Shaping Tomorrow's Management in EGFRm NSCLC The Art of Medicine in Lung Cancer
|
|
|
1610-1700 | Advanced Lung Cancer Chairpersons: Amir Shah |
Advanced Breast Cancer Chairpersons: Kiley Loh |
Cancer genomics Chairpersons: |
1610-1630 | Management Of Oligometastatic Disease In Lung Cancer James Yang, Taiwan |
Weighing The Cost And Benefits Of Novel Therapies In Metastatic Breast Cancer Ho Gwo Fuang |
Genetic Testing in Clinic: A Practical Guide Yoon Sook Yee |
1630-1650 | Post-Progression Management For Advanced Nslcl With Driver Mutation Treated With TKI |
MDT Case Discussion Samuel Ow, Singapore Teoh Mei Shi Ivy Ho |
Riding the Genomic Wave: Medical Genetics and Therapy Winnie Ong |
1650-1700 | Q&A | Q&A | Q&A |
1900-2200 | CONGRESS DINNER (R.S.V.P ONLY) |
SATURDAY, 12 OCTOBER 2024
TIME | BALLROOM 1 | BALLROOM 2 | BALLROOM 3 |
0830-0900 | REGISTRATION | ||
0900-0945 | SCIENTIFIC PLENARY (IV) RESEARCH - Overcoming challenges in oncological clinical trials (phase 1-3) in Malaysia Chairperson: Speaker: Dr Voon Pei Jye |
||
0945-1000 | Repartitioning of halls | ||
1000-1045 |
EBC / Abema |
Unveiling the Future: Redefining ALKare into Chronic Disease |
|
1045 - 1155 | Gynecologic Oncology Chairpersons: Ang Soo Fan |
Lower GI Chairpersons: |
Head & Neck Chairpersons: Ho Kean Fatt |
1045-1105 | New Standard Of Care For Locally Advanced And Metastatic Cervical Cancer Jennifer Leong |
Neoadjuvant Strategies For Locally Advanced Rectal Cancer - TNT, How To Implement This In Malaysia Patricia Shamani Soosainathan |
Reinventing The Wheel For Radiotherapy In Nasopharyngeal Carcinoma Melvin Chua, Singapore |
1105-1125 | Endometrial Cancer – Landmark Trials & Biomarker Directed Therapies John Chia Whay Kuang, Singapore |
Update: Management Of Peritoneal Metastasis: Hipec Is Not Hot Air! James Khaw Chern Wern |
Transoral Robotic Surgery - Malaysian Experience Mohd Razif Mohamad Yunus Ahmad Kusyairi Khalid |
1125-1145 | MDT Cases Discussion: Stage I Ovarian, Recurrence Ovarian on PARP-i, Locally Advanced Cervical, Carcinosarcoma of Uterus; Metastatic Endometrial Cancer, etc Presenter: Ang Soo Fan Panel: Jennifer Leong John Chia Whay Kuang Chew Ghee Kheng |
Updates Systemic Therapy For Metastatic Colorectal Cancer Nur Fadhilina Abdul Satar |
Metastatic Head And Neck Carcinoma - Changing Treatment Paradigm Wan Zamaniah Bt Wan Ishak |
1145-1155 | Q&A | Q&A | Q&A |
1155-1305 | Nursing Chairpersons: |
Prostate Chairpersons: |
Nuclear Medicine Chairpersons: |
1155-1215 | Optimal Care Of Vascular Implanted Devices Punitha A/P Arumohan |
Hypofractionated Or Ultrahypofractionated Prostate Radiotherapy? Thiraviyam Elumalai, United Kingdom |
Diagnostic Nuclear Medicine For Solid Tumours In Malaysia Au Mun Yee |
1215-1235 | Optimal Management Of Fungating Breast Wound Norhashimah Bt Khadir |
Dosimetric Advantages Of Spacers In Prostate Radiotherapy Michael Chao, Australia |
Therapeutic Nuclear Medicine For Solid Tumours In Malaysia Alex Khoo Chee Hoe |
1255-1305 | Q&A | Q&A | Q&A |
1305 - 1405 |
|
Metastatic Gastric Ca |
|
1405-1510 | CNS Chairpersons: |
Bladder Chairpersons: Shazril Imran |
Physics/Radiation therapist Chairpersons: |
1405-1425 | Tumour Treating Fields (TTF) For The Management Of Glioma - The Asian Experience Daniel Chan, Singapore |
Cost Effective Treatment For Muscle Invasive Bladder Cancer For Developing Countries Nuradh Joseph, Sri Lanka |
SBRT Liver Motion Management Practice in Malaysia (Radiation Therapist Perspective) Mohd Khairul b. Mohd Zambri |
1425-1445 | Is There A Role For Targeted Therapy In Gliomas? Sith Sathornsumetee, Thailand |
Is Radiosensiting Radical Radiotherapy in Bladder, Superior Than Surgery? Thiraviyam Elumalai, United Kingdom |
Overcoming Challenges in SBRT for The Spine Zulaikha Jamalludin |
1445-1505 | Management Of G2/3 Glioma Or Case Discussion Sith Sathornsumetee, Thailand |
Optimal Management Of Metastatic Urothelial Carcinoma Ravindran Kanesvaran, Sinagpore |
SBRT for Challenging Sites: Intrahepatic, Renal, and Pericardial Lesions Robin Hill, Australia |
1505-1510 | Q&A | Q&A | Q&A |
1510-1555 |
|
|
|
1555-1645 | Research Chairpersons: |
Kidney Chairpersons: |
Immunotherapy Chairpersons: |
1555-1615 | Implementing Radiotherapy Related Research in a Developing Country Nuradh Joseph, Sri Lanka |
Adjuvant Therapy in Renal Cell Carcinoma : Where Do We Now Stand? Adlinda Bt Alip |
Updates in Predictive Markers for Immunotherapy and Treatment of Solid Tumours Lee Fong Wan |
1615-1635 | Delivering Support for a Successful Investigator Initiated Research in Oncology Yoon Chee Kin |
Systemic Therapy Metastatic Renal Cell, Sequencing Optimal Therapy Lee Cheen Leng |
Recognising Rare and Lethal Immunotherapy Related Adverse Events and Management Nellie Cheah Lay Chin |
1635-1645 | Q&A | Q&A | Q&A |
1700-1900 | ANNUAL GENERAL MEETING (MOS MEMBERS ONLY) |
SUNDAY, 13 OCTOBER 2024
TIME | BALLROOM 1 | BALLROOM 2 | BALLROOM 3 |
0830-0900 | REGISTRATION | ||
0900-0945 | SCIENTIFIC PLENARY (III) ARTIFICIAL INTELLIGENCE: Improving cancer diagnostics and therapeutics using artificial Intelligence - current state of affair and future potentials. Speaker: Prof Junya Fukuoka, Japan |
||
0945-1000 | Repartitioning of halls | ||
1000-1045 |
Minimal Residual Disease Monitoring Comprehensive Genomics Profiling for Target Therapy Selection |
|
TEA SYMPOSIUM 3-3 |
1045-1200 | Upper GI Chairpersons: Nellie Cheah Lay Chin & Lim Shyang Yee |
Sarcoma Chairpersons: Ho Kean Fatt |
Palliative Care Chairpersons: Doris Chow Sze Ying |
1045-1105 | Oligomets in Upper GI Cancer - Any Role of Surgery? Lim Shyang Yee |
Giant Cell Tumours - An Update Prashant Narhari |
National Pain Management CPG (2nd Edition) Aaron Hiew Wi Han |
1105-1125 | Peri-Operative Treatment In Upper Gi Cancer Eng Jie Yi |
Managing "Whoops!" Surgery Tan Ai Lian Prashant Narhari |
Dying Well - Myth or Possibility Oo Loo Chan |
1125-1145 | Radiotherapy For Ugi Ca - Current Status And Future Direction Maria Hawkins, United Kingdom |
GIST Updates Wong Yoke Fui |
Advanced Care Plan - What Is It? Lim Liang Yik |
1145-1200 | Q&A | Q&A | Q&A |
1200-1315 | Thyroid Chairpersons: Yap Beng Khiong |
Free Paper Oral Presentations Chairpersons: Eunice Ong |
Patient Advocacy Chairpersons: |
1200-1220 | Sequencing Therapies for Metastatic Thyroid Carcinoma | Navigating Public Healthcare With a Diagnosis Of Cancer Sazrah Bt Shuib |
|
1220-1240 | Management of Low Risk Thyroid Carcinoma Alex Khoo Chee Hoe |
Where To Find Support After Diagnosis Of Cancer? Jimmy Kijon |
|
1240-1300 | Anaplastic/Poorly Differentiated Thyroid Carcinoma - What Are Our Options Choong Swee Hsia |
Surviving Cancer - How To Carry On? Loo Chia Ming |
|
1300-1315 | Q&A | Judging session | Q&A |
1315-1345 | CLOSING CEREMONY |
DISCLAIMER: Whilst every attempt would be made to ensure all aspects of the conference mentioned in the Programme will take place as scheduled, the Organising Committee assumes no responsibility should it fail to materialize due to any unforeseen circumstances.